Haemonetics Anticoagulant Sodium Citrate is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Trisodium Citrate Dihydrate.
| Product ID | 57826-420_6ad8c143-892a-7ce1-e053-2a91aa0a6d78 |
| NDC | 57826-420 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Haemonetics Anticoagulant Sodium Citrate |
| Generic Name | Trisodium Citrate Dihydrate |
| Dosage Form | Solution |
| Route of Administration | EXTRACORPOREAL |
| Marketing Start Date | 2013-01-10 |
| Marketing Category | NDA / NDA |
| Application Number | BN980123 |
| Labeler Name | Haemonetics Corporation |
| Substance Name | TRISODIUM CITRATE DIHYDRATE |
| Active Ingredient Strength | 40 mg/mL |
| Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2013-01-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | BN980123 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-01-10 |
| Ingredient | Strength |
|---|---|
| TRISODIUM CITRATE DIHYDRATE | 40 mg/mL |
| SPL SET ID: | 447528e6-55cd-4a9b-868e-2a741b2693d3 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 57826-420 | Haemonetics Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE |
| 76297-006 | Anticoagulant Sodium Citrate | Trisodium Citrate Dihydrate |
| 81839-782 | Anticoagulant Sodium Citrate | Trisodium Citrate Dihydrate |
| 14537-881 | Sodium Citrate 4% w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE |
| 14537-883 | Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE |
| 23731-6030 | triCitrasol | Trisodium Citrate dihydrate |